BRENT WETENDORF: Open Payments
NPI 1134437346 · WICHITA FALLS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$875 in 44 payments from 12 companies in 2025. Trend: 2023 $831 · 2024 $728 · 2025 $875
Food & beverage: $875
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $253 |
| Novo Nordisk Inc | 7 | $106 |
| Antares Pharma, Inc. | 6 | $104 |
| Novartis Pharmaceuticals Corporation | 4 | $96 |
| GlaxoSmithKline, LLC. | 4 | $74 |
| ABBVIE INC. | 4 | $69 |
| Phathom Pharmaceuticals, Inc. | 2 | $41 |
| Amgen Inc. | 2 | $33 |
| Intra-Sana Laboratories | 2 | $31 |
| Supernus Pharmaceuticals, Inc. | 1 | $30 |
Products named: FARXIGA, XYOSTED, LEQVIO, Wegovy, AIRSUPRA, TRELEGY ELLIPTA, VOQUEZNA, UBRELVY.
Industry payments across TX — which companies pay providers there.
